Gelteq Limited (GELS)
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia.
$0.56+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-65.4%
The outlook
Gelteq Limited currently reads as bearish based on below its 50- & 200-day averages, 11% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Market cap
$6.0M
52-wk high
$2.02
52-wk low
$0.39
50-day avg
$0.64
200-day avg
$0.81
Trailing P/E
—